Ambros Therapeutics

Ambros develops medicines for diseases with high unmet medical need. Its lead investigational program targets complex regional pain syndrome type 1.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2025